These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 26919248)

  • 21. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
    PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer.
    Frydrychowicz M; Kolecka-Bednarczyk A; Madejczyk M; Yasar S; Dworacki G
    Scand J Immunol; 2015 Jan; 81(1):2-10. PubMed ID: 25359529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.
    Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP; Kerin MJ; Dwyer RM
    Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal miRNAs as biomarkers of recurrent lung cancer.
    Munagala R; Aqil F; Gupta RC
    Tumour Biol; 2016 Aug; 37(8):10703-14. PubMed ID: 26867772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Exosomal Noncoding RNAs in Lung Carcinogenesis.
    Sun T; Kalionis B; Lv G; Xia S; Gao W
    Biomed Res Int; 2015; 2015():125807. PubMed ID: 26583084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs in extracellular vesicles: potential cancer biomarkers.
    Kinoshita T; Yip KW; Spence T; Liu FF
    J Hum Genet; 2017 Jan; 62(1):67-74. PubMed ID: 27383658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
    Yang JS; Li BJ; Lu HW; Chen Y; Lu C; Zhu RX; Liu SH; Yi QT; Li J; Song CH
    Tumour Biol; 2015 Apr; 36(4):3035-42. PubMed ID: 25501703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
    Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal non-coding RNAs: a promising cancer biomarker.
    Yang H; Fu H; Xu W; Zhang X
    Clin Chem Lab Med; 2016 Dec; 54(12):1871-1879. PubMed ID: 27166723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
    Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
    Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.